Fibrinolysis Flashcards
1
Q
process of fibrinolysis mainly mediated by
A
plasmin - breaks down fibrin
2
Q
too much fibrinolysis
A
risk of bleeding
3
Q
too little fibrinolysis
A
risk of thrombosis
4
Q
system designed to digest and remove fibrin clots to re-establish blood flow through an injured vessel
A
- fibrinolytic system
- plasmin
- fibrinolytic proteins incorporated into fibrin clot = keeps fibrinolysis localized
- activated a few hours after clot formation
5
Q
fibrinolytic system components
A
- plasminogen (acts on fibrin primarily; can also break down fibrinogen)
- activators: endogenous, exogenous
- substrates: fibrinogen and fibrin
- inhibitors: alpha2-antiplasmin, plasminogen activator inhibitor, thrombin-activatable fibrinolysis inhibitor
6
Q
where is plasminogen made?
A
liver
7
Q
T or F. Plasmine is a serin protease
A
T
8
Q
when free plasmin digests fibrin, factors V, VIII
A
primary fibrinolysis disorder
9
Q
alpha 2-antiplasmin
A
inactivates plasmin
10
Q
plasminogen activators
A
- endogenous (inside body): intrinsic activators + extrinsic activators
- exogenous: recombinant TPA (rTPA), urokinase, streptokinase; used for therapeutic reasons - storke, MI, etc.
11
Q
intrinsic activators (plasminogen activators)
A
- in plasma
- XIIa, kallikrein, XIa, HMWK
12
Q
extrinsic activators (plasminogen activators)
A
- not in plasma
- tissue plasminogen activator (TPA)
- urokinase/urokinase plasminogen activator (UPA)
13
Q
streptokinase
A
- exogenous (from bacteria; beta-hem streptococci)
- not specific for fibrin; lso digests fibrinogen
- drawback when using as clot buster = potential immune response
14
Q
thrombin time
A
- assessing specific portion of coag pathway
- uses dilute thrombin reagent
- measure time for thrombin to convert fibrinogen to fibrin clot
- detects presence of thrombin inhibitors and low/abnormal fibrinogen
15
Q
prolonged thrombin time
A
- hypofibrinogenemia/dysfibrinogenemia
- heparin
- fibrin degradation products